Contemporary medical therapy for polycystic ovary syndrome
- 28 September 2006
- journal article
- review article
- Published by Wiley in International Journal of Gynecology & Obstetrics
- Vol. 95 (3) , 236-241
Abstract
Polycystic ovary syndrome is a multi‐system endocrinopathy with long‐term metabolic and cardiovascular health consequences. Patients typically present due to symptoms of irregular menstruation, hair growth, or infertility; however, recent management options are aimed at further treating underlying glucose–insulin abnormalities as well as androgen excess for proactive control of symptoms. By a 2003 international consensus conference, diagnosis is made by two out of three criteria: chronic oligoovulation or anovulation after excluding secondary causes, clinical or biochemical evidence of hyperandrogenism (but not necessarily hirsutism due to inter‐patient variability in hair follicle sensitivity), and radiological evidence of polycystic ovaries. Traditional medical treatment options include oral contraceptive pills, cyclic progestins, ovulation induction, and anti‐androgenic medications (aldosterone antagonist, 5α‐reductase antagonist, and follicle ornithine decarboxylase inhibitor). Recent pharmacotherapies include insulin‐sensitizing medications metformin and two thiazolidinediones (rosiglitazone/Avandia® and pioglitazone/Actos®), a CYP19 aromatase inhibitor (letrozole/Femara®), and statins to potentially lower testosterone levels.Keywords
This publication has 42 references indexed in Scilit:
- Two weeks of metformin improves clomiphene citrate-induced ovulation and metabolic profiles in women with polycystic ovary syndromeFertility and Sterility, 2006
- Evidence for metabolic and reproductive phenotypes in mothers of women with polycystic ovary syndromeProceedings of the National Academy of Sciences, 2006
- Simvastatin improves biochemical parameters in women with polycystic ovary syndrome: results of a prospective, randomized trialFertility and Sterility, 2006
- Efficacy of a new oral contraceptive containing drospirenone and ethinyl estradiol in the long-term treatment of hirsutismFertility and Sterility, 2006
- Combined oral contraceptives in the treatment of polycystic ovary syndromeHuman Reproduction Update, 2005
- Incidence of polycystic ovaries and polycystic ovary syndrome amongst women in Melbourne, AustraliaAustralian and New Zealand Journal of Obstetrics and Gynaecology, 2005
- Mevastatin inhibits ovarian theca–interstitial cell proliferation and steroidogenesisFertility and Sterility, 2004
- The role of ultrasound and Doppler analysis in the diagnosis of polycystic ovary syndromeUltrasound in Obstetrics & Gynecology, 2003
- ACOG practice bulletin #34. management of infertility caused by ovulatory dysfunctionObstetrics & Gynecology, 2002
- Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome.Journal of Clinical Investigation, 1995